Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls
暂无分享,去创建一个
Claus Svarer | John Dickson | Andrea Varrone | Catharina Lange | Ralph Buchert | Osama Sabri | Hidehiro Iida | Flavio Nobili | Livia Tossici-Bolt | Jan Booij | Andreas Kluge | Terez Sera | Klaus Tatsch | Marcus Bronzel | Marco Pagani | R. Buchert | C. Svarer | H. Iida | K. Laere | A. Varrone | F. Nobili | J. Dickson | O. Sabri | K. Tatsch | T. Borght | P. Koulibaly | J. Booij | S. Asenbaum | T. Sera | L. Tossici-Bolt | A. Kluge | M. Pagani | C. Lange | Susanne Asenbaum | L. Özlem Atay Kapucu | Pierre-Malick Koulibaly | Thierry Borght | Koen Laere | L. Ö. Atay Kapucu | M. Bronzel | Livia Tossici-Bolt
[1] H. Iida,et al. Quantitative assessment of regional myocardial blood flow with thallium-201 and SPECT , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[2] John Seibyl,et al. SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.
[3] K. Ogawa,et al. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] E.-S. Kim,et al. Multiperiodic states and bifurcations in bunch lengthening by a localized impedance in electron storage ring , 2001 .
[5] Dag Aarsland,et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. , 2004, Archives of neurology.
[6] Stefan Eberl,et al. Multicenter Evaluation of a Standardized Protocol for Rest and Acetazolamide Cerebral Blood Flow Assessment Using a Quantitative SPECT Reconstruction Program and Split-Dose 123I-Iodoamphetamine , 2010, The Journal of Nuclear Medicine.
[7] R. C. Oldfield. The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.
[8] H Amthauer,et al. Global scaling for semi-quantitative analysis in FP-CIT SPECT , 2014, Nuklearmedizin.
[9] H. Iida,et al. SPECT collimator dependency of scatter and validation of transmission dependent scatter compensation methodologies , 2000, 2000 IEEE Nuclear Science Symposium. Conference Record (Cat. No.00CH37149).
[10] Markus Nowak Lonsdale,et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Z Walker,et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.
[12] D. Jennings,et al. Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease Patients , 2007, Journal of Nuclear Medicine.
[13] I. McKeith,et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study , 2007, The Lancet Neurology.
[14] D. Bailey,et al. A transmission-dependent method for scatter correction in SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] Perry E Radau,et al. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] John S. Fleming,et al. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[17] K. Tatsch,et al. Quantitative approaches to dopaminergic brain imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[18] John S Fleming,et al. The specific uptake size index for quantifying radiopharmaceutical uptake. , 2004, Physics in medicine and biology.
[19] Osama Sabri,et al. Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies , 2013, The Journal of Nuclear Medicine.
[20] K. Ogawa,et al. A practical method for position-dependent Compton-scatter correction in single photon emission CT. , 1991, IEEE transactions on medical imaging.
[21] Hidehiro Iida,et al. Reproducibility of Cerebral Blood Flow Assessment using a Quantitative SPECT Reconstruction Program and Split-Dose 123I-Iodoamphetamine in Institutions with Different γ-Cameras and Collimators , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] J D Speelman,et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[23] Kenji Ishida,et al. Three-dimensional brain phantom containing bone and grey matter structures with a realistic head contour , 2012, Annals of Nuclear Medicine.
[24] Koen Van Laere,et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[25] Jan Booij,et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.
[26] S Eberl,et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] J B Habraken,et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] D. Guilloteau,et al. Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I , 1999, NeuroImage.
[29] H Iida,et al. Monte Carlo and experimental evaluation of accuracy and noise properties of two scatter correction methods for SPECT , 1996, Physics in medicine and biology.
[30] Stefan Eberl,et al. Design and experimental validation of a quantitative myocardial /sup 201/Tl SPECT system , 1998 .
[31] J. Darcourt,et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[32] Klaus Tatsch,et al. Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update , 2013, The Journal of Nuclear Medicine.
[33] Wim Vandenberghe,et al. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[34] H. Malcolm Hudson,et al. Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.
[35] K. Laere,et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[36] P. Armitage,et al. Statistical methods in medical research. , 1972 .
[37] L S Graham,et al. Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee. , 1995, Medical physics.